|
[1]
|
Cabell, C.H., Heidenreich, P.A., Chu, V.H., Moore, C.M., Stryjewski, M.E., Corey, G.R. and Fowler, V.G. (2004) Increasing Rates of Cardiac Device Infections among Medicare Beneficiaries: 1990-1999. American Heart Journal, 147, 582-586. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Voigt, A., Shalaby, A., Saba, S., et al. (2006) Rising Rates of Cardiac Rhythm Management Device Infections in the United States: 1996 through 2003. Journal of the American College of Cardiology, 48, 590-591. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Baddour, L.M., Bettmann, M.A., Bolger, A.F., et al. (2003) Nonvalvular Cardiovascular Device-Related Infections. Circulation, 108, 2015-2031. [Google Scholar] [CrossRef]
|
|
[4]
|
Tarakji, K.G., Chan, E.J., Cantillon, D.J., Doonan, A.L., Hu, T., Schmitt, S., Fraser, T.G., Kim, A., Gordon, S.M. and Wilkoff, B.L. (2010) Cardiac Implantable Electronic Device Infections: Presentation, Management, and Patient Outcomes. Heart Rhythm, 7, 1043-1047. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Chua, J.D., Abdul-Karim, A., Mawhorter, S., Procop, G.W., Tchou, P., Niebauer, M., Saliba, W., Schweikert, R. and Wilkoff, B.L. (2005) The Role of Swab and Tissue Culture in the Diagnosis of Implantable Cardiac Device Infection. Pacing and Clinical Electrophysiology, 28, 1276-1281. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Kleemann, T., Becker, T., Strauss, M., et al. (2010) Prevalence of Bacterial Colonization of Generator Pockets in Implantable Cardioverter Defibrillator Patients without Signs of Infection Undergoing Generator Replacement or Lead Revision. Europace, 12, 58-63. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
刘俊鹏, 杨杰孚, 佟佳宾, 等. 心血管植入型电子器械更换患者无症状囊袋感染相关危险因素研究[J]. 中华心律失常学杂志, 2013(6): 422-426.
|
|
[8]
|
Baddour, L.M., Epstein, A.E., Erickson, C.C., et al. (2010) Update on Cardiovascular Implantable Electronic Device Infections and Their Management: A Scientific Statement from the American Heart Association. Circulation, 121, 458-477. [Google Scholar] [CrossRef]
|
|
[9]
|
Johansen, J.B., Jorgensen, O.D., Moller, M. and Arnsbo, P. (2011) Infection after Pacemaker Implantation: Infection Rates and Risk Factors Associated with Infection in a Population-Based Cohort Study of 46299. European Heart Journal, 32, 991-998. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Lekkerkerker, J.C., van Nieuwkoop, C., Trines, S.A., van der Bom, J.G., Bernards, A., van de Velde, E.T., Bootsma, M., Zeppenfeld, K., Jukema, J.W., Borleffs, J.W., Schalij, M.J. and van Erven, L. (2009) Risk Factors and Time Delay Associated with Cardiac Device Infections: Leiden Device Registry. Heart, 95, 715-720. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Habid, A., Muna, I., Baddour, L.M., et al. (2013) Impact of Prior Aspirin Therapy on Clinical Manifestations of Cardiovascular Implantable Electronic Device Infections. Europace, 15, 227-235. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Pichlmaier, M., Marwitz, V., Kuhn, C., et al. (2008) High Prevalence of Asymptomatic Bacterial Colonization of Rhythm Management Devices. Europace, 10, 1067-1072. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Pepys, M.B., Hirschfield, G.M., Pepys, M.B. and Hirschfield, G.M. (2003) C-Reactive Protein: A Critical Update. Journal of Clinical Investigation, 111, 1805-1812. [Google Scholar] [CrossRef]
|
|
[14]
|
Assicot, M., Bohuon, C., Gendrel, D., Raymond, J., Carsin, H. and Guilbaud, J. (1993) High Serum Procalcitonin Concentrations in Patients with Sepsis and Infection. The Lancet, 341, 515-518. [Google Scholar] [CrossRef]
|
|
[15]
|
Xing, Z., Gauldie, J., Cox, G., Baumann, H., Jordana, M., Lei, X.F. and Achong, M.K. (1998) IL-6 Is an Antiinflammatory Cytokine Required for Controlling Local or Systemic Acute Inflammatory Responses. The Journal of Clinical Investigation, 101, 311-320. [Google Scholar] [CrossRef]
|
|
[16]
|
Schuetz, P., Mueller, B. and Trampuz, A. (2007) Serum Procalcitonin for Discrimination of Blood Contamination from Bloodstream Infection Due to Coagulase-Negative Staphylococci. Infection, 35, 352-355. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Becker, K.L., Snider, R. and Nylen, E.S. (2008) Procalcitonin Assay in Systemic Inflammation, Infection, and Sepsis: Clinical Utility and Limitations. Critical Care Medicine, 36, 941-952. [Google Scholar] [CrossRef]
|
|
[18]
|
Zou, T., Zhang, Z.G., Zou, C.G., et al. (2014) Subclinical Infections of Cardiac Implantable Electronic Devices: Insights into the Host-Bacteria Dialog from Blood and Pocket Tissue with Pyrosequencing. International Journal of Cardiology, 174, 545-549. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Schultzle, H., Forster, J. and Superti-Furga, A. (2009) Is Serum Procalcitonin a Reliable Diagnostic Marker in Children with Acute Respiratory Tract Infections. European Journal of Pediatrics, 168, 117-1124. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Ingram, P.R., Inglis, T. and Moxon, D. (2010) Procalcitonin and C-Reactive Protein in Severe H1N1 Influenza Infection. Intensive Care Medicine, 36, 528-532. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Carsin, H., Assicot, M., Feger, F., et al. (1997) Evolution and Significance of Circulating Procalcitonin Levels Compared with Il-6, TNF-α, and Endotoxin Levels Early after Thermal Injury. Burns, 23, 218-224. [Google Scholar] [CrossRef]
|
|
[22]
|
Riedel, S. (2012) Procalcitonin and the Role of Biomarkers in the Diagnosis and Management of Sepsis. Diagnostic Microbiology & Infectious Disease, 73, 221-227. [Google Scholar] [CrossRef] [PubMed]
|